CRP and lung cancer: Elevated CRP levels [8], elevated serum levels of pro-inflammatory cytokines [10–12], increased neutrophil counts and decreased lymphocyte counts [13, 14], and polymorphisms in inflammation-related genes [15–18] have been associated with increased lung cancer risk.